SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001169245-20-000075
Filing Date
2020-08-11
Accepted
2020-08-11 16:22:54
Documents
65
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q phas-20200630.htm   iXBRL 10-Q 1822499
2 EX-31.1 ex311-phas10xq2020q2.htm EX-31.1 12185
3 EX-31.2 ex312-phas10xq2020q2.htm EX-31.2 12176
4 EX-32.1 ex-321xphas10xq2020q2.htm EX-32.1 5950
5 EX-32.2 ex-322xphas10xq2020q2.htm EX-32.2 5944
  Complete submission text file 0001169245-20-000075.txt   6077414

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT phas-20200630.xsd EX-101.SCH 43389
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT phas-20200630_cal.xml EX-101.CAL 65095
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT phas-20200630_def.xml EX-101.DEF 204199
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT phas-20200630_lab.xml EX-101.LAB 501664
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT phas-20200630_pre.xml EX-101.PRE 317628
11 EXTRACTED XBRL INSTANCE DOCUMENT phas-20200630_htm.xml XML 756257
Mailing Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355
Business Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355 (610) 981-6500
PhaseBio Pharmaceuticals Inc (Filer) CIK: 0001169245 (see all company filings)

IRS No.: 030375697 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38697 | Film No.: 201092720
SIC: 2834 Pharmaceutical Preparations